Press releases
- Tandem Diabetes Care to Announce Second Quarter 2024 Financial Results on August 1, 2024
- Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions
- Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer
- Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association’s 84th Scientific Sessions
- Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
- Tandem Diabetes Care Announces Upcoming Conference Presentation
- Tandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial Guidance
- Tandem Diabetes Care Announces Upcoming Conference Presentations
More ▼
Key statistics
On Monday, Tandem Diabetes Care Inc (T2ND34:SAO) closed at 16.96, -10.26% below its 52-week high of 18.90, set on May 27, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 15.78 |
---|---|
High | 16.96 |
Low | 15.71 |
Bid | 16.97 |
Offer | 16.97 |
Previous close | 15.92 |
Average volume | 337.60 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Jul 22 2024 21:10 BST.
More ▼